US Stock MarketDetailed Quotes

ADMA Biologics (ADMA)

Watchlist
  • 11.260
  • +0.180+1.62%
Close Apr 24 16:00 ET
  • 11.290
  • +0.030+0.27%
Post 19:59 ET
2.62BMarket Cap18.77P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADMA Biologics (ADMA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
19.63%510.17M
18.39%139.16M
12.00%134.22M
13.80%121.98M
40.22%114.8M
65.15%426.45M
59.06%117.55M
78.13%119.84M
78.29%107.19M
43.86%81.88M
Operating revenue
19.63%510.17M
18.39%139.16M
12.00%134.22M
13.80%121.98M
40.22%114.8M
65.15%426.45M
59.06%117.55M
78.13%119.84M
78.29%107.19M
43.86%81.88M
Cost of revenue
5.08%217.41M
-7.14%50.35M
-2.63%58.6M
10.09%54.76M
25.58%53.71M
22.23%206.9M
26.62%54.22M
41.19%60.18M
14.52%49.74M
5.86%42.77M
Gross profit
33.35%292.77M
40.24%88.82M
26.76%75.63M
17.01%67.23M
56.23%61.1M
146.85%219.55M
103.73%63.33M
141.99%59.66M
244.24%57.45M
136.83%39.11M
Operating expense
25.76%101.32M
4.22%26.07M
22.94%24.61M
33.84%24.43M
51.65%26.22M
19.70%80.57M
48.40%25.01M
25.38%20.02M
6.35%18.25M
-0.23%17.29M
Selling and administrative expenses
23.55%91.58M
0.84%23.51M
17.33%21.78M
33.75%22.21M
53.97%24.08M
25.59%74.12M
50.09%23.32M
26.04%18.56M
16.56%16.61M
7.77%15.64M
Research and development costs
162.66%4.76M
251.92%1.38M
270.87%1.53M
84.11%1.03M
83.56%826K
-45.06%1.81M
-12.33%391K
-30.87%412K
-60.09%560K
-47.37%450K
Depreciation amortization depletion
-62.89%144K
104.00%51K
35.71%38K
-77.46%32K
-87.05%25K
-46.41%388K
-86.63%25K
-84.36%28K
-20.67%142K
7.82%193K
-Depreciation and amortization
-62.89%144K
104.00%51K
35.71%38K
-77.46%32K
-87.05%25K
-46.41%388K
-86.63%25K
-84.36%28K
-20.67%142K
7.82%193K
Other operating expenses
13.92%4.84M
-11.82%1.13M
24.58%1.27M
22.29%1.15M
27.96%1.29M
-0.49%4.25M
86.42%1.28M
118.63%1.02M
-29.33%942K
-43.54%1.01M
Operating profit
37.75%191.44M
63.74%62.75M
28.69%51.01M
9.18%42.8M
59.85%34.88M
542.49%138.98M
169.25%38.32M
356.40%39.64M
8,387.74%39.2M
2,784.01%21.82M
Net non-operating interest income expense
55.73%-5.24M
50.07%-1.14M
54.15%-1.3M
56.99%-1.43M
59.62%-1.37M
49.45%-11.83M
59.29%-2.28M
52.59%-2.83M
43.35%-3.33M
43.10%-3.39M
Non-operating interest income
-10.78%1.87M
-18.56%487K
-43.54%376K
-10.91%400K
58.33%608K
29.68%2.1M
-2.29%598K
57.45%666K
8.45%449K
131.33%384K
Non-operating interest expense
-48.96%7.11M
-43.52%1.63M
-52.13%1.68M
-51.52%1.83M
-47.60%1.98M
-44.34%13.93M
-53.68%2.88M
-45.31%3.5M
-39.94%3.78M
-38.36%3.77M
Other net income (expense)
-147.08%-3.55M
98.72%-17K
-3,825.00%-2.2M
-7,818.75%-1.27M
-82.86%-64K
94.57%-1.44M
94.94%-1.33M
61.38%-56K
-23.08%-16K
-29.63%-35K
Special income (charges)
-168.38%-3.34M
--0
---2.18M
---1.16M
----
95.25%-1.24M
---1.24M
--0
--0
----
-Less:Other special charges
168.38%3.34M
--0
--2.18M
--1.16M
----
-95.25%1.24M
----
----
----
----
Other non- operating income (expenses)
-9.84%-212K
80.23%-17K
62.50%-21K
-575.00%-108K
-82.86%-64K
32.75%-193K
14.85%-86K
61.38%-56K
-23.08%-16K
-29.63%-35K
Income before tax
45.29%182.66M
77.44%61.6M
29.30%47.52M
11.84%40.1M
81.78%33.45M
545.18%125.71M
296.73%34.71M
1,332.71%36.75M
662.72%35.85M
371.04%18.4M
Income tax
149.65%35.73M
115.83%12.22M
1,219.88%11.09M
55.13%5.88M
1,000.17%6.55M
-71.96M
-77.18M
840K
3.79M
595K
Net income
-25.67%146.93M
-55.87%49.38M
1.45%36.43M
6.73%34.22M
51.10%26.9M
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
Net income continuous Operations
-25.67%146.93M
-55.87%49.38M
1.45%36.43M
6.73%34.22M
51.10%26.9M
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
Minority interest income
Net income attributable to the parent company
-25.67%146.93M
-55.87%49.38M
1.45%36.43M
6.73%34.22M
51.10%26.9M
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.67%146.93M
-55.87%49.38M
1.45%36.43M
6.73%34.22M
51.10%26.9M
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
Basic earnings per share
-27.06%0.62
-55.32%0.21
0.00%0.15
0.00%0.14
37.50%0.11
753.85%0.85
687.50%0.47
1,400.00%0.15
566.67%0.14
366.67%0.08
Diluted earnings per share
-25.93%0.6
-56.52%0.2
0.00%0.15
7.69%0.14
37.50%0.11
723.08%0.81
675.00%0.46
1,400.00%0.15
533.33%0.13
366.67%0.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 19.63%510.17M18.39%139.16M12.00%134.22M13.80%121.98M40.22%114.8M65.15%426.45M59.06%117.55M78.13%119.84M78.29%107.19M43.86%81.88M
Operating revenue 19.63%510.17M18.39%139.16M12.00%134.22M13.80%121.98M40.22%114.8M65.15%426.45M59.06%117.55M78.13%119.84M78.29%107.19M43.86%81.88M
Cost of revenue 5.08%217.41M-7.14%50.35M-2.63%58.6M10.09%54.76M25.58%53.71M22.23%206.9M26.62%54.22M41.19%60.18M14.52%49.74M5.86%42.77M
Gross profit 33.35%292.77M40.24%88.82M26.76%75.63M17.01%67.23M56.23%61.1M146.85%219.55M103.73%63.33M141.99%59.66M244.24%57.45M136.83%39.11M
Operating expense 25.76%101.32M4.22%26.07M22.94%24.61M33.84%24.43M51.65%26.22M19.70%80.57M48.40%25.01M25.38%20.02M6.35%18.25M-0.23%17.29M
Selling and administrative expenses 23.55%91.58M0.84%23.51M17.33%21.78M33.75%22.21M53.97%24.08M25.59%74.12M50.09%23.32M26.04%18.56M16.56%16.61M7.77%15.64M
Research and development costs 162.66%4.76M251.92%1.38M270.87%1.53M84.11%1.03M83.56%826K-45.06%1.81M-12.33%391K-30.87%412K-60.09%560K-47.37%450K
Depreciation amortization depletion -62.89%144K104.00%51K35.71%38K-77.46%32K-87.05%25K-46.41%388K-86.63%25K-84.36%28K-20.67%142K7.82%193K
-Depreciation and amortization -62.89%144K104.00%51K35.71%38K-77.46%32K-87.05%25K-46.41%388K-86.63%25K-84.36%28K-20.67%142K7.82%193K
Other operating expenses 13.92%4.84M-11.82%1.13M24.58%1.27M22.29%1.15M27.96%1.29M-0.49%4.25M86.42%1.28M118.63%1.02M-29.33%942K-43.54%1.01M
Operating profit 37.75%191.44M63.74%62.75M28.69%51.01M9.18%42.8M59.85%34.88M542.49%138.98M169.25%38.32M356.40%39.64M8,387.74%39.2M2,784.01%21.82M
Net non-operating interest income expense 55.73%-5.24M50.07%-1.14M54.15%-1.3M56.99%-1.43M59.62%-1.37M49.45%-11.83M59.29%-2.28M52.59%-2.83M43.35%-3.33M43.10%-3.39M
Non-operating interest income -10.78%1.87M-18.56%487K-43.54%376K-10.91%400K58.33%608K29.68%2.1M-2.29%598K57.45%666K8.45%449K131.33%384K
Non-operating interest expense -48.96%7.11M-43.52%1.63M-52.13%1.68M-51.52%1.83M-47.60%1.98M-44.34%13.93M-53.68%2.88M-45.31%3.5M-39.94%3.78M-38.36%3.77M
Other net income (expense) -147.08%-3.55M98.72%-17K-3,825.00%-2.2M-7,818.75%-1.27M-82.86%-64K94.57%-1.44M94.94%-1.33M61.38%-56K-23.08%-16K-29.63%-35K
Special income (charges) -168.38%-3.34M--0---2.18M---1.16M----95.25%-1.24M---1.24M--0--0----
-Less:Other special charges 168.38%3.34M--0--2.18M--1.16M-----95.25%1.24M----------------
Other non- operating income (expenses) -9.84%-212K80.23%-17K62.50%-21K-575.00%-108K-82.86%-64K32.75%-193K14.85%-86K61.38%-56K-23.08%-16K-29.63%-35K
Income before tax 45.29%182.66M77.44%61.6M29.30%47.52M11.84%40.1M81.78%33.45M545.18%125.71M296.73%34.71M1,332.71%36.75M662.72%35.85M371.04%18.4M
Income tax 149.65%35.73M115.83%12.22M1,219.88%11.09M55.13%5.88M1,000.17%6.55M-71.96M-77.18M840K3.79M595K
Net income -25.67%146.93M-55.87%49.38M1.45%36.43M6.73%34.22M51.10%26.9M800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M
Net income continuous Operations -25.67%146.93M-55.87%49.38M1.45%36.43M6.73%34.22M51.10%26.9M800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M
Minority interest income
Net income attributable to the parent company -25.67%146.93M-55.87%49.38M1.45%36.43M6.73%34.22M51.10%26.9M800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.67%146.93M-55.87%49.38M1.45%36.43M6.73%34.22M51.10%26.9M800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M
Basic earnings per share -27.06%0.62-55.32%0.210.00%0.150.00%0.1437.50%0.11753.85%0.85687.50%0.471,400.00%0.15566.67%0.14366.67%0.08
Diluted earnings per share -25.93%0.6-56.52%0.20.00%0.157.69%0.1437.50%0.11723.08%0.81675.00%0.461,400.00%0.15533.33%0.13366.67%0.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -